Skip to content

Test for Pre Operative Skin Preparations

Test for Pre Operative Skin Preparations: ChloraPrep Triple Swabsticks, Hibiclens and Sterile Triple Swabsticks (Using Sterile Deionized Water)

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00799812
Enrollment
335
Registered
2008-12-01
Start date
2007-11-13
Completion date
2008-06-19
Last updated
2025-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topical Antisepsis

Keywords

antimicrobial, antisepsis

Brief summary

Compare 2 application techniques of ChloraPrep Swabstick--3 swabsticks at once versus 3 swabsticks used sequentially. Hibiclens applied according to the manufacturer's directions. Sterile swabsticks (wetted with sterile deionizd water) applied using the same method as the ChloraPrep Swabstick.

Detailed description

Determine differences (if any) in 2 different application techniques of ChloraPrep Swabstick--3 swabsticks at once versus 3 swabsticks used sequentially. Hibiclens, a liquid antibacterial soap, applied according to the manufacturer's directions as a active/positive comparison. Sterile swabsticks (wetted with sterile deionized water) applied as a negative comparison using the same method as the ChloraPrep swabstick. Study uses topical sampling from the abdomen and the groin on intact skin and evaluates the germs left on the skin after treatment with ChloraPrep Swabsticks.

Interventions

DRUGCHG 2% w/v & IPA 70% v/v, swabstick (3 @ once).

3 swabsticks topically applied at the same time to intact skin

DRUGCHG 2% w/v & IPA 70% v/v swab applied sequentially

Chlorhexidine gluconate 2% w/v and isopropyl alcohol 70% v/v; 3 swabsticks applied sequentially to intact skin.

DRUGAqueous CHG 4% w/v applied according to mfr's directions

Chlorhexidine gluconate 4% w/v in an aqueous base applied according to mfr's directions. Step 1) 5 ml of Hibiclens applied to a sterile gauze pad. Step 2) Product applied to treatment area on intact skin for 2 minutes. Area dried with sterile towel or sterile gauze. Steps 1 and 2 repeated.

OTHERSterile swabstick with sterile water (3 @ once)

3 sterile swabsticks wetted with sterile water topically applied to intact skin at the same time.

OTHERSterile swabstick with sterile water (one-at-a-time)

Sterile swabsticks wetted with sterile water topically applied to intact skin one-at-a-time.

Sponsors

C. R. Bard
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subjects must read and sign an Informed Consent Form and be cooperative. * Subjects must be in good general health. * Subjects must have skin within 6 inches of the test site that is free of tattoos, dermatoses, abrasions, cuts, lesions, or other skin disorders.

Exclusion criteria

* Use of systemic or topical antimicrobials during the 2-week pretest conditioning period. This restriction includes but is not limited to shampoos, lotions, soaps, baby powders, and materials, such as solvents, acids, or alkalis. * A medical diagnosis of a physical condition, which would preclude participation such as: diabetes, hepatitis, an organ transplant, a medical surgical implant, or an immunocompromised system. * Any medical condition that in the opinion of the investigator would preclude participation. * Bathed in chemically treated pools or hot tubs 2 weeks prior to any microbial sampling. * Used UV tanning lamps 2 weeks prior to any microbial sampling. * Bathing or showering less than 48 hours prior to any microbial sampling. * Known sensitivity to chlorhexidine gluconate. * Known sensitivity to latex (rubber). * Known sensitivity to fragrances. * Pregnant or nursing. * Unwillingness to fulfill the performance requirements of the study. * Subjects who have completed part or all of the study will not be reentered in the study.

Design outcomes

Primary

MeasureTime frameDescription
log10 Reductions From Baseline for Each Test Parameter in CFU (Colony Forming Unit)/cm2 on Inguinal and Abdominal Sites10 minutes and 6 hours after application of test solutionsThe bacterial reductions achieved by the test products and the controls using 2 different application techniques at 10-minute and 6-hour sampling intervals for both groin and abdominal sites were evaluated.

Countries

United States

Participant flow

Pre-assignment details

Each subject received more than one treatment. Randomization was done by testing site and each subject had 4 testing sites.

Participants by arm

ArmCount
All Study Participants
All Participants Who Completed Evaluations
335
Total335

Baseline characteristics

CharacteristicAll Study Participants
371-121 Preoperative Skin Preparations
CHG Swabstick (3 @ Once)
139 Participants
371-121 Preoperative Skin Preparations
CHG Swabstick (Sequential)
138 Participants
371-121 Preoperative Skin Preparations
Hibiclens
133 Participants
371-121 Preoperative Skin Preparations
Sterile Water Swab (3 @ Once)
132 Participants
371-121 Preoperative Skin Preparations
Sterile Water Swabstick (Sequential)
126 Participants
Age, Continuous34.9 years
STANDARD_DEVIATION 14.1
Sex: Female, Male
All Participants
Female
149 Participants
Sex: Female, Male
All Participants
Male
186 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
deaths
Total, all-cause mortality
0 / 1390 / 1380 / 1330 / 1320 / 126
other
Total, other adverse events
0 / 1390 / 1380 / 1330 / 1320 / 126
serious
Total, serious adverse events
0 / 1390 / 1380 / 1330 / 1320 / 126

Outcome results

Primary

log10 Reductions From Baseline for Each Test Parameter in CFU (Colony Forming Unit)/cm2 on Inguinal and Abdominal Sites

The bacterial reductions achieved by the test products and the controls using 2 different application techniques at 10-minute and 6-hour sampling intervals for both groin and abdominal sites were evaluated.

Time frame: 10 minutes and 6 hours after application of test solutions

Population: Measure Analysis Population Description: Number analyzed is not equal to participants treated but rather equal to the number of treated sites for individuals who met the baseline bacterial load criteria on treatment day

ArmMeasureGroupValue (MEAN)Dispersion
CHG Swabstick (3 @ Once)log10 Reductions From Baseline for Each Test Parameter in CFU (Colony Forming Unit)/cm2 on Inguinal and Abdominal SitesGroin site - 10 minutes3.51 Average log10 reductions in CFU/cm2Standard Deviation 0.62
CHG Swabstick (3 @ Once)log10 Reductions From Baseline for Each Test Parameter in CFU (Colony Forming Unit)/cm2 on Inguinal and Abdominal SitesGroin site - 6 hours3.22 Average log10 reductions in CFU/cm2Standard Deviation 0.65
CHG Swabstick (3 @ Once)log10 Reductions From Baseline for Each Test Parameter in CFU (Colony Forming Unit)/cm2 on Inguinal and Abdominal SitesAbdomen site - 10 minutes2.56 Average log10 reductions in CFU/cm2Standard Deviation 0.5
CHG Swabstick (3 @ Once)log10 Reductions From Baseline for Each Test Parameter in CFU (Colony Forming Unit)/cm2 on Inguinal and Abdominal SitesAbdomen site - 6 hours2.38 Average log10 reductions in CFU/cm2Standard Deviation 0.6
CHG Swabstick Sequentiallog10 Reductions From Baseline for Each Test Parameter in CFU (Colony Forming Unit)/cm2 on Inguinal and Abdominal SitesGroin site - 10 minutes3.44 Average log10 reductions in CFU/cm2Standard Deviation 0.64
CHG Swabstick Sequentiallog10 Reductions From Baseline for Each Test Parameter in CFU (Colony Forming Unit)/cm2 on Inguinal and Abdominal SitesAbdomen site - 6 hours2.39 Average log10 reductions in CFU/cm2Standard Deviation 0.64
CHG Swabstick Sequentiallog10 Reductions From Baseline for Each Test Parameter in CFU (Colony Forming Unit)/cm2 on Inguinal and Abdominal SitesGroin site - 6 hours3.24 Average log10 reductions in CFU/cm2Standard Deviation 0.58
CHG Swabstick Sequentiallog10 Reductions From Baseline for Each Test Parameter in CFU (Colony Forming Unit)/cm2 on Inguinal and Abdominal SitesAbdomen site - 10 minutes2.58 Average log10 reductions in CFU/cm2Standard Deviation 0.48
Hibiclenslog10 Reductions From Baseline for Each Test Parameter in CFU (Colony Forming Unit)/cm2 on Inguinal and Abdominal SitesAbdomen site - 6 hours2.51 Average log10 reductions in CFU/cm2Standard Deviation 0.66
Hibiclenslog10 Reductions From Baseline for Each Test Parameter in CFU (Colony Forming Unit)/cm2 on Inguinal and Abdominal SitesGroin site - 6 hours2.89 Average log10 reductions in CFU/cm2Standard Deviation 0.62
Hibiclenslog10 Reductions From Baseline for Each Test Parameter in CFU (Colony Forming Unit)/cm2 on Inguinal and Abdominal SitesAbdomen site - 10 minutes2.76 Average log10 reductions in CFU/cm2Standard Deviation 0.49
Hibiclenslog10 Reductions From Baseline for Each Test Parameter in CFU (Colony Forming Unit)/cm2 on Inguinal and Abdominal SitesGroin site - 10 minutes3.15 Average log10 reductions in CFU/cm2Standard Deviation 0.53
Sterile Water Swab (3 @ Once)log10 Reductions From Baseline for Each Test Parameter in CFU (Colony Forming Unit)/cm2 on Inguinal and Abdominal SitesGroin site - 10 minutes0.92 Average log10 reductions in CFU/cm2Standard Deviation 0.47
Sterile Water Swab (3 @ Once)log10 Reductions From Baseline for Each Test Parameter in CFU (Colony Forming Unit)/cm2 on Inguinal and Abdominal SitesGroin site - 6 hours0.82 Average log10 reductions in CFU/cm2Standard Deviation 0.47
Sterile Water Swab (3 @ Once)log10 Reductions From Baseline for Each Test Parameter in CFU (Colony Forming Unit)/cm2 on Inguinal and Abdominal SitesAbdomen site - 6 hours0.47 Average log10 reductions in CFU/cm2Standard Deviation 0.38
Sterile Water Swab (3 @ Once)log10 Reductions From Baseline for Each Test Parameter in CFU (Colony Forming Unit)/cm2 on Inguinal and Abdominal SitesAbdomen site - 10 minutes0.54 Average log10 reductions in CFU/cm2Standard Deviation 0.37
Sterile Water Swabstick (Sequential)log10 Reductions From Baseline for Each Test Parameter in CFU (Colony Forming Unit)/cm2 on Inguinal and Abdominal SitesAbdomen site - 6 hours0.46 Average log10 reductions in CFU/cm2Standard Deviation 0.39
Sterile Water Swabstick (Sequential)log10 Reductions From Baseline for Each Test Parameter in CFU (Colony Forming Unit)/cm2 on Inguinal and Abdominal SitesAbdomen site - 10 minutes0.50 Average log10 reductions in CFU/cm2Standard Deviation 0.35
Sterile Water Swabstick (Sequential)log10 Reductions From Baseline for Each Test Parameter in CFU (Colony Forming Unit)/cm2 on Inguinal and Abdominal SitesGroin site - 6 hours0.85 Average log10 reductions in CFU/cm2Standard Deviation 0.58
Sterile Water Swabstick (Sequential)log10 Reductions From Baseline for Each Test Parameter in CFU (Colony Forming Unit)/cm2 on Inguinal and Abdominal SitesGroin site - 10 minutes0.97 Average log10 reductions in CFU/cm2Standard Deviation 0.55

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026